Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation
Shu Su(Monash University), Lei Zhang(Zhengzhou University), Dan Dan Cheng(University of Hong Kong - Shenzhen Hospital), Zhuoru Zou(Xi'an Jiaotong University), Polin Chan(Western University), Fanpu Ji(Shanxi Medical University), Man‐Fung Yuen(University of Hong Kong - Shenzhen Hospital), Guihua Zhuang(Xi'an Jiaotong University), William C.W. Wong(University of Hong Kong - Shenzhen Hospital), Wai‐Kay Seto(State Key Laboratory of Synthetic Chemistry), Jason J. Ong(Monash University)
Cited by 122
Related Papers
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
|Gut and Liver|2016|512
HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma
|Gastroenterology|2008|409
Global reporting of progress towards elimination of hepatitis B and hepatitis C
|The Lancet. Gastroenterology & hepatology|2023|323
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection
|New England Journal of Medicine|2022|264
Hepatitis B virus infection in children and adolescents
|The Lancet. Gastroenterology & hepatology|2019|258